Trial Profile
Multicenter, Observational Study to Evaluate NeoRecormon Treatment in Anemic Patients Suffering From Non-myeloid Malignancy Receiving Chemotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2016
Price :
$35
*
At a glance
- Drugs Epoetin beta (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Roche
- 29 Nov 2016 New trial record
- 11 Oct 2016 Results assessing safety and efficacy using data from this and CT01168349 trials presented at the 41st European Society for Medical Oncology Congress